Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 103740

In scope icon M 11 E
QID 103740 (Type "103740" in App Search)
A 25-year-old man is evaluated is brought to the psychiatry clinic by his parents who state that his paranoid delusions and hallucinations have been worsening over the past several weeks. He was diagnosed with schizophrenia two months prior and started on risperidone. He initially responded well to this medication and was able to return to work. However, his parents state that he has been unable to take his medication on a daily basis. They state that when he forgets to take his medication, often for several days at a time, he has a return of his symptoms. His temperature is 98.6°F (37.0°C), pulse is 90, blood pressure is 130/90 mmHg, and respirations are 18. He appears to be responding to internal stimuli. He answers questions, but his speech is tangential and thought blocking is evident. Which of the following would be the most appropriate next step in management?

Continue risperidone therapy and observe

0%

0/5

Switch to aripiprazole

0%

0/5

Switch to clozapine

20%

1/5

Switch to haloperidol

20%

1/5

Switch to long-acting injectable risperidone formulation

60%

3/5

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

Patients with a history of psychosis and medication noncompliance can be treated with a long-acting injectable form of antipsychotic medication. Risperidone, haloperidol decanoate, and fluphenazine are all antipsychotics that are also available in a long-acting, injectable formulation.

Risperidone is an atypical antipsychotic medication that acts at both D2 receptors and serotonin receptors. This class of drugs poses a lower risk for extrapyramidal symptoms and tardive dyskinesia than typical antipsychotics. The atypical antipsychotics commonly cause weight gain or metabolic syndrome, as well as QT interval prolongation. Long-acting injectable formulations of atypical antipsychotics cause similar adverse effects to those seen with oral typical antipsychotics. For patients who respond well to an atypical antipsychotic but are unable to take medication daily, long-acting injectable formulations are an option to ensure better compliance. They are typically administered once per month.

Pacchiarotti et. al review the use of long-acting injectable antipsychotics for the management of bipolar and schizoaffective disorders. They note that patients with psychotic disorders often have issues with medication compliance for a number of reasons. They discuss the risks and benefits of long-acting injectable use in these patients.

Illustration A is a chart showing the various adverse effects of both typical and atypical antipsychotics.

Incorrect Answers:
Answer 1: This patient has been unable to remain compliant with risperidone therapy and has had a worsening of his condition as a result. Therefore, remaining on risperidone with observation would not be appropriate.

Answer 2: Aripiprazole is another atypical antipsychotic that is sometimes used for management of schizophrenia. However, this patient had a good response to risperidone, suggesting that a long-acting formulation of risperidone would be a better first step in management.

Answer 3: Clozapine is an atypical antipsychotic that is associated with potentially life-threatening side effects such as seizures, agranulocytosis, and myocarditis. For this reason, it is typically reserved for patients that have failed therapy with at least two other antipsychotic medications.

Answer 4: Haloperidol is a high potency typical antipsychotic that carriers a higher risk of extrapyramidal symptoms when compared to atypical antipsychotics. For that reason, it is typically not used for the long-term management of schizophrenia.

Bullet Summary:
Patients with schizophrenia that are unable to remain compliant on antipsychotic medication may be switched to a long-acting injectable formulation of antipsychotic medication to improve compliance and better control symptoms.

ILLUSTRATIONS:
REFERENCES (1)
Authors
Rating
Please Rate Question Quality

4.2

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(6)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options